Pechnor

Pechnor is a specialized dermatological cream designed primarily for managing hyperpigmentation, melasma, and uneven skin tone. The formulation typically combines potent skin-brightening agents such as Kojic Acid, Arbutin, and various vitamins to inhibit melanin production and promote a clearer complexion. It is widely prescribed in clinical dermatology for patients seeking to reduce dark spots and post-inflammatory hyperpigmentation.

The brand originated in India, where it was developed to cater to the specific needs of South Asian skin types, which are often prone to pigmentary disorders. It is manufactured under strict quality control standards in Indian pharmaceutical facilities. The brand is managed and distributed by Lifeline Remedies, a pharmaceutical company focused on providing affordable yet high-quality therapeutic solutions across various medical segments including dermatology and general healthcare.

As of 2026, Pechnor remains a key product within the Lifeline Remedies portfolio. The company maintains its headquarters in India, overseeing the domestic distribution and potential export of its dermatological range. While it is a niche pharmaceutical brand rather than a global consumer conglomerate product, it has established a strong reputation among healthcare professionals for its efficacy and reliability in treating skin-related concerns.